Who makes [14C] MK-5475?

[14C] MK-5475 is developed by Merck Sharp & Dohme LLC.

Last reviewed 2026-04-19 · How we verify

[14C] MK-5475

Merck Sharp & Dohme LLC · Phase 1 active Small molecule

At a glance

Generic name	[14C] MK-5475
Sponsor	Merck Sharp & Dohme LLC
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C] MK-5475 CI brief — competitive landscape report
[14C] MK-5475 updates RSS · CI watch RSS
Merck Sharp & Dohme LLC portfolio CI